Man Group PLC : Form 8.3 - - Amendment Amendment to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
35
Man Group PLC : Form 8.3 - [Cape plc] - Amendment

Amendment to section 1

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Man Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):                                                                      N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:                                                                      Cape plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken:                                                                      11 th July 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      YES / NO / N/A If YES, specify which:  

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   25p ordinary
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 707,416 0.5841 0 0
(2) Cash-settled derivatives:   262,518 0.2168 0 0
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0 0 0
       TOTAL: 969,934 0.8009 0 0

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
25p Ordinary Sale 24,900 2.6220
25p Ordinary Sale 36,500 2.6220
25p Ordinary Sale 200,000 2.6325
25p Ordinary Sale 1,300,000 2.6213
25p Ordinary Sale 227,642 2.6211

(b)        Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP)
25p Ordinary CFD Reducing a long position 14,600 2.6220
25p Ordinary CFD Reducing a long position 24,800 2.6220
25p Ordinary CFD Reducing a long position 6,400 2.6220
25p Ordinary CFD Reducing a long position 6,000 2.6220
25p Ordinary CFD Reducing a long position 21,500 2.6220
25p Ordinary CFD Reducing a long position 9,200 2.6220
25p Ordinary CFD Reducing a long position 3,400 2.6220
25p Ordinary CFD Reducing a long position 7,900 2.6220
25p Ordinary CFD Reducing a long position 2,300 2.6220
25p Ordinary CFD Reducing a long position 31,200 2.6220

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
           

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
       

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
  None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None  

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES/ NO
Date of disclosure: 12 th July 2017
Contact name: Matthew Irwin
Telephone number: 02071447255

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OUTFRONT Media Gears Up for Q3 2026 Earnings Reveal

Updated Category News Views 0

OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...

Continue Reading
Fresenius Revamps U.S. Kidney Care with multiFiltratePRO

Updated Category News Views 2

Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...

Continue Reading
Eightpoint Backs Community Shelter with Vital Aid

Updated Category News Views 2

Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...

Continue Reading
Pediatric Dental Visits: Setting the Stage Early Matters

Updated Category News Views 1

Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...

Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq

Updated Category News Views 2

Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...

Continue Reading
PrimoHoagies Expanding: New Franchisees and Big Moves

Updated Category News Views 3

Fresh Bites of Opportunity at PrimoHoagies Head down to Philly and you'll catch wind of a tasty venture cooking up some buzz: PrimoHoagies is diving into 2026 with seven fresh franchisees under their wing. What you've got here isn't some scrappy startup grasping at straws, but a solid name packing over three decades under its belt. When experienced restaurant operators...

Continue Reading
Labcorp Scoops Up BioReference Health For $722M+

Updated Category News Views 2

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Continue Reading
Liver Disease Summit Fosters Awareness and Community

Updated Category News Views 7

Gathering for a Greater Cause in Chicago The American Liver Foundation (ALF) hosted a summit in the Windy City that was as much about heart as it was about livers. This wasn’t just another sterile conference; it was a grassroots rally for those battling metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease...

Continue Reading
Samsung Biologics' Big Gains and Ambitious Moves in 2026

Updated Category News Views 9

A Robust Third Quarter Samsung Biologics is making some serious noise in the biopharma sector with its latest Q3 2026 financial results. We're talking about KRW 1,490 billion in revenue, an uptick that screams growth, backed by an operating profit of KRW 640 billion. What's fueling this engine? Their relentless plant expansion and a pivotal step into the U.S. market....

Continue Reading
Glint: Lovense's New Era in Intimacy Tech

Updated Category News Views 7

From Thrill to Touch: The Glint Debut Screw the traditional remote control for sex toys! Lovense is straight up flipping the script with Glint. This isn't about adding more buttons or connecting another app. We're talking about a butt plug that lets your partner's thrust set the whole vibe. Forget fumbling with phones in the heat of the moment—this toy syncs your...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Growth of $100 Invested in KKR Over a Decade

Updated Category News Views 137

The Remarkable Growth of KKR Over the Past Decade Investing in KKR (NYSE: KKR) ten years ago would have been a smart move for any investor. Throughout this decade, KKR has consistently outperformed market expectations, achieving an impressive annualized return of 19.49%. This standout performance exceeds the market average by 8.29%, highlighting the potential of strategic...

Continue Reading
Therap Services Launches T-Log Module for Enhanced Communication

Updated Category News Views 233

Enhancing Communication with Therap's T-Log Module Therap Services, a prominent player in the realm of HIPAA-compliant electronic documentation solutions, is committed to empowering agencies within the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS), and various other human services sectors. With the introduction of its innovative T-Log...

Continue Reading
BioMarin Secures $850 Million in Senior Notes for Growth Strategy

Updated Category News Views 98

BioMarin Unveils New Funding Strategy for Expansion BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) recently announced its successful pricing of a significant offering of $850 million in senior unsecured notes, due 2034. These notes carry a fixed interest rate of 5.500%, with an issue price set at 100.000%. The anticipated closing date for this offering is just around the...

Continue Reading
Piramal Pharma Limited's Financial Highlights for Q3 FY25

Updated Category News Views 388

Piramal Pharma Limited Financial Results Overview Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635) has announced compelling results for the third quarter (Q3) and the first nine months (9M) of FY25, highlighting a strong performance in the pharmaceutical and wellness sectors. Consolidated Financial Highlights The company reported significant financial metrics, with...

Continue Reading
Five Star Development Navigates Chapter 11 for Project Completion

Updated Category News Views 368

Five Star Development Takes Steps for Project Protection Five Star Development, LLC, alongside affiliated entities, has recently announced its decision to file for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court. This pivotal move aims to ensure that the ambitious project known as The Palmeraie, which includes The Ritz-Carlton Paradise Valley, can be...

Continue Reading